The following license files are associated with this item:
- QMRO Home
- Barts Cancer Institute
- Centre for Tumour Biology
- Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells (vol 25, pg 259, 2017)
Browse
Administrators only